Triumph Science&Technology Co Ltd
SSE:600552
Balance Sheet
Balance Sheet Decomposition
Triumph Science&Technology Co Ltd
Current Assets | 5.5B |
Cash & Short-Term Investments | 534.1m |
Receivables | 2.2B |
Other Current Assets | 2.8B |
Non-Current Assets | 5.8B |
PP&E | 4.9B |
Intangibles | 859.9m |
Other Non-Current Assets | 46.3m |
Balance Sheet
Triumph Science&Technology Co Ltd
Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
801
|
188
|
317
|
218
|
241
|
544
|
678
|
661
|
302
|
232
|
|
Cash |
0
|
0
|
0
|
0
|
0
|
0
|
179
|
661
|
302
|
232
|
|
Cash Equivalents |
801
|
188
|
317
|
218
|
241
|
544
|
499
|
0
|
0
|
0
|
|
Short-Term Investments |
15
|
0
|
3
|
45
|
89
|
0
|
0
|
737
|
71
|
302
|
|
Total Receivables |
1 063
|
1 366
|
1 403
|
1 526
|
1 841
|
1 808
|
1 876
|
1 563
|
2 145
|
2 167
|
|
Accounts Receivables |
773
|
1 011
|
1 019
|
1 060
|
1 394
|
1 317
|
1 181
|
934
|
1 293
|
1 272
|
|
Other Receivables |
291
|
355
|
384
|
467
|
447
|
492
|
695
|
629
|
852
|
894
|
|
Inventory |
742
|
952
|
1 157
|
1 566
|
1 688
|
1 740
|
1 849
|
1 919
|
2 039
|
2 414
|
|
Other Current Assets |
232
|
422
|
340
|
457
|
543
|
549
|
242
|
434
|
863
|
337
|
|
Total Current Assets |
2 853
|
2 928
|
3 220
|
3 812
|
4 403
|
4 642
|
4 645
|
5 313
|
5 419
|
5 452
|
|
PP&E Net |
1 204
|
1 370
|
1 459
|
1 631
|
1 935
|
2 221
|
3 097
|
3 515
|
3 968
|
4 911
|
|
PP&E Gross |
1 204
|
1 370
|
1 459
|
1 631
|
1 935
|
2 221
|
3 097
|
3 515
|
3 968
|
4 911
|
|
Accumulated Depreciation |
360
|
393
|
490
|
558
|
587
|
652
|
1 235
|
1 487
|
1 548
|
1 785
|
|
Intangible Assets |
264
|
351
|
326
|
343
|
340
|
433
|
512
|
549
|
607
|
668
|
|
Goodwill |
254
|
254
|
232
|
196
|
196
|
196
|
196
|
196
|
192
|
192
|
|
Long-Term Investments |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
25
|
28
|
30
|
38
|
42
|
41
|
57
|
54
|
47
|
46
|
|
Other Assets |
254
|
254
|
232
|
196
|
196
|
196
|
196
|
196
|
192
|
192
|
|
Total Assets |
4 601
N/A
|
4 931
+7%
|
5 266
+7%
|
6 021
+14%
|
6 916
+15%
|
7 533
+9%
|
8 509
+13%
|
9 626
+13%
|
10 233
+6%
|
11 269
+10%
|
|
Liabilities | |||||||||||
Accounts Payable |
370
|
570
|
424
|
612
|
793
|
803
|
975
|
648
|
800
|
887
|
|
Accrued Liabilities |
35
|
39
|
35
|
38
|
62
|
73
|
112
|
102
|
86
|
94
|
|
Short-Term Debt |
1 562
|
1 237
|
1 293
|
1 649
|
2 157
|
2 311
|
1 952
|
1 208
|
1 352
|
2 211
|
|
Current Portion of Long-Term Debt |
40
|
6
|
36
|
705
|
134
|
857
|
366
|
827
|
1 169
|
731
|
|
Other Current Liabilities |
137
|
159
|
142
|
92
|
58
|
110
|
538
|
1 163
|
1 194
|
974
|
|
Total Current Liabilities |
2 144
|
2 011
|
1 928
|
3 096
|
3 203
|
4 153
|
3 942
|
3 948
|
4 600
|
4 897
|
|
Long-Term Debt |
7
|
297
|
683
|
219
|
889
|
477
|
1 043
|
1 108
|
976
|
1 579
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Minority Interest |
104
|
132
|
159
|
186
|
229
|
277
|
293
|
385
|
422
|
463
|
|
Other Liabilities |
84
|
133
|
126
|
117
|
104
|
92
|
99
|
103
|
158
|
160
|
|
Total Liabilities |
2 339
N/A
|
2 573
+10%
|
2 896
+13%
|
3 618
+25%
|
4 426
+22%
|
4 999
+13%
|
5 376
+8%
|
5 544
+3%
|
6 157
+11%
|
7 099
+15%
|
|
Equity | |||||||||||
Common Stock |
384
|
384
|
767
|
764
|
764
|
764
|
764
|
945
|
945
|
945
|
|
Retained Earnings |
521
|
597
|
636
|
679
|
767
|
811
|
485
|
549
|
623
|
716
|
|
Additional Paid In Capital |
1 357
|
1 377
|
968
|
960
|
960
|
960
|
1 883
|
2 588
|
2 509
|
2 509
|
|
Total Equity |
2 262
N/A
|
2 358
+4%
|
2 371
+1%
|
2 403
+1%
|
2 490
+4%
|
2 535
+2%
|
3 132
+24%
|
4 082
+30%
|
4 077
0%
|
4 170
+2%
|
|
Total Liabilities & Equity |
4 601
N/A
|
4 931
+7%
|
5 266
+7%
|
6 021
+14%
|
6 916
+15%
|
7 533
+9%
|
8 509
+13%
|
9 626
+13%
|
10 233
+6%
|
11 269
+10%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
767
|
767
|
767
|
764
|
764
|
764
|
764
|
945
|
945
|
945
|